Markets & Regulations

© GettyImages/AndreyPopov

Disruptor in cell and gene therapy space secures US$30m in funding

By Jane Byrne

Ori Biotech Ltd (Ori), a London and New Jersey based innovator in the cell and gene therapy (CGT) manufacturing sphere, last week announced the successful close of a US$30m Series A financing round, bringing the company’s total funding to date to US$41m.

© GettyImages/YurolaitsAlbert

Lilly's COVID-19 antibody trial on hold over safety concerns

By Jane Byrne

Enrollment is temporarily on hold in the ACTIV-3 clinical trial, which is evaluating Lilly's investigational neutralizing antibody bamlanivimab (LY-CoV555) as a treatment for COVID-19 in hospitalized patients. The pause was recommended by the study's...

(fizkes/iStock via Getty Images Plus)

CPhI Festival of Pharma

CPhI, Pharmapack Europe to return in 2021

By Jenni Spinner

The popular pharma industry conferences plan to combine live and digital elements when assembling its calendar of international events next year.

© GettyImages/iLexx

BARDA and Locus in tie-up to tackle UTIs with phages

By Jane Byrne

Locus Biosciences has signed a contract with BARDA to co-fund development of LBP-EC01, a CRISPR Cas3-enhanced bacteriophage (crPhage) that targets E. coli bacteria causing recurrent urinary tract infections (UTIs).

Pic:getty/daniilantiq

Industry welcomes release of FDA COVID-19 vaccine guidance

By Rachel Arthur

On Tuesday the FDA released its guidance on Emergency Use Authorization for COVID-19 vaccines: a move welcomed by the industry as a ‘tried and true tradition of releasing guidance in a public and transparent way’.

Follow us

Products

View more

Webinars